Browse By: Country ι Category ι Tag
Home  »  Bladder Cancer

Bladder Cancer Market Research Reports

More

Global Superficial Bladder Cancer Drugs Market Professional Survey Report 2016
Production, means the output of Superficial Bladder Cancer Drugs Revenue, means the sales value of Superficial Bladder Cancer Drugs This report studies Superficial Bladder Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Altor BioScience Corporation APIM Therapeutics AS Bavarian Nordic A/S Cold Genesys, Inc. Spectrum Pharmaceuticals, Inc. Telesta Therapeutics Inc. UroGen Pharmaceuticals, Ltd. Viventia Bio Inc. endo pharmaceutical SANOFI By types, the market can be split into Type
Published Date: Dec 2016
Published By: QYResearch

Price: $3500
Valstar (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Valstar (Bladder Cancer) Analysis and Forecasts to 2020 provides Valstar global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2009-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile inc
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Iressa (Bladder Cancer) - Analysis and Forecast to 2020
GlobalDatas pharmaceuticals report, Iressa (Bladder Cancer) - Analysis and Forecast to 2020 provides Iressa global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile incl
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Ellence (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Ellence (Bladder Cancer) Analysis and Forecasts to 2020 provides Ellence EU sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2012). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Note: This is a on-demand report and w
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Tykerb (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Tykerb (Bladder Cancer) Analysis and Forecasts to 2020 provides Tykerb global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile inclu
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Eoquin (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Eoquin (Bladder Cancer) Analysis and Forecasts to 2020 provides Eoquin global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile inclu
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Javlor (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Javlor (Bladder Cancer) Analysis and Forecasts to 2020 provides Javlor global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2010-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile inclu
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Mitomycin (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Mitomycin (Bladder Cancer) Analysis and Forecasts to 2020 provides Javlor global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile in
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
MVAC (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, MVAC (Bladder Cancer) Analysis and Forecasts to 2020 provides MVAC global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile including
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
BCG (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, BCG (Bladder Cancer) Analysis and Forecasts to 2020 provides BCG global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This is a on-demand report and will be
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Gemzar (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Gemzar (Bladder Cancer) Analysis and Forecasts to 2020 provides Gemzar global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile inclu
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Thiotepa (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Thiotepa (Bladder Cancer) Analysis and Forecasts to 2020 provides Thiotepa global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile i
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Urocidin (Bladder Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Urocidin (Bladder Cancer) Analysis and Forecasts to 2020 provides Urocidin global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile i
Published Date: Oct 2011
Published By: GlobalData

Price: $2000

Back To Top